314 related articles for article (PubMed ID: 26865450)
1. Real-world multicentre experience with the Direct Flow Medical repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis.
Naber CK; Pyxaras SA; Ince H; Latib A; Frambach P; den Heijer P; Wagner D; Butter C; Colombo A; Kische S
EuroIntervention; 2016 Feb; 11(11):e1314-20. PubMed ID: 26865450
[TBL] [Abstract][Full Text] [Related]
2. A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis.
Naber CK; Pyxaras SA; Ince H; Frambach P; Colombo A; Butter C; Gatto F; Hink U; Nickenig G; Bruschi G; Brueren G; Tchétché D; Den Heijer P; Schillinger W; Scholtz S; Van der Heyden J; Lefèvre T; Gilard M; Kuck KH; Schofer J; Divchev D; Baumgartner H; Asch F; Wagner D; Latib A; De Marco F; Kische S
EuroIntervention; 2016 Dec; 12(11):e1413-e1419. PubMed ID: 27934611
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.
Meredith Am IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Allocco DJ; Dawkins KD
J Am Coll Cardiol; 2014 Sep; 64(13):1339-48. PubMed ID: 25257635
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
[TBL] [Abstract][Full Text] [Related]
5. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
Zhang Y; Pyxaras SA; Wolf A; Schmitz T; Naber CK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1217-25. PubMed ID: 25581785
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort.
Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T
Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455
[TBL] [Abstract][Full Text] [Related]
7. First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†.
Schaefer A; Harmel E; Seiffert M; Reichart D; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
Interact Cardiovasc Thorac Surg; 2017 May; 24(5):659-662. PubMed ID: 28329312
[TBL] [Abstract][Full Text] [Related]
8. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
9. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.
Treede H; Mohr FW; Baldus S; Rastan A; Ensminger S; Arnold M; Kempfert J; Figulla HR
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e131-8. PubMed ID: 22508111
[TBL] [Abstract][Full Text] [Related]
10. Transfemoral Implantation of a Fully Repositionable and Retrievable Transcatheter Valve for Noncalcified Pure Aortic Regurgitation.
Schofer J; Nietlispach F; Bijuklic K; Colombo A; Gatto F; De Marco F; Mangieri A; Hansen L; Bruschi G; Ruparelia N; Rieß FC; Maisano F; Latib A
JACC Cardiovasc Interv; 2015 Dec; 8(14):1842-9. PubMed ID: 26604062
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter, inflatable, and fully repositionable aortic valve: Preliminary results using a modified implantation technique.
Kische S; D'Ancona G; Agma HU; Gürer H; Ortak J; Elsässer A; Öner A; Ince H
Catheter Cardiovasc Interv; 2016 Feb; 87(3):500-7. PubMed ID: 26013307
[TBL] [Abstract][Full Text] [Related]
12. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve.
Schofer J; Colombo A; Klugmann S; Fajadet J; DeMarco F; Tchétché D; Maisano F; Bruschi G; Latib A; Bijuklic K; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Lefevre T
J Am Coll Cardiol; 2014 Mar; 63(8):763-8. PubMed ID: 24211506
[TBL] [Abstract][Full Text] [Related]
13. One-year outcomes after direct transcatheter aortic valve implantation with a self-expanding bioprosthesis. A two-center international experience.
Toutouzas K; Latsios G; Stathogiannis K; Drakopoulou M; Synetos A; Sanidas E; Mastrokostopoulos A; Trantalis G; Kaitozis O; Lazaros G; Yuecel S; Gerckens U; Grube E; Tousoulis D
Int J Cardiol; 2016 Jan; 202():631-5. PubMed ID: 26451789
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter Aortic Valve Implantation in High-Risk/Inoperable Patients: Repositionable versus Non-Repositionable Self-Expanding Valve.
Veulemans V; Sötemann DB; Kleinebrecht L; Keymel S; Jung C; Zeus T; Kelm M; Westenfeld R
J Heart Valve Dis; 2017 Jul; 26(4):405-412. PubMed ID: 29302939
[TBL] [Abstract][Full Text] [Related]
15. TRINITY heart valve prosthesis: a novel repositionable and retrievable transapical transcatheter aortic valve system.
Hengstenberg C; Condado J; Garcia D; Martinez MM; La Forgia G; Ebner A; Gallo S; Silva E; Holzamer A; Husser O; Hilker M
EuroIntervention; 2015 Mar; 10(11):1332-5. PubMed ID: 25022228
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter aortic valve implantation for paradoxical low-flow low-gradient aortic stenosis patients.
Debry N; Sudre A; Amr G; Delhaye C; Schurtz G; Montaigne D; Koussa M; Modine T
Catheter Cardiovasc Interv; 2016 Mar; 87(4):797-804. PubMed ID: 26424679
[TBL] [Abstract][Full Text] [Related]
17. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve.
Wenaweser P; Stortecky S; Schütz T; Praz F; Gloekler S; Windecker S; Elsässer A
EuroIntervention; 2016 May; 12(1):71-7. PubMed ID: 27173865
[TBL] [Abstract][Full Text] [Related]
19. Transaortic valve implantation with the direct flow medical valve in an emergency situation of post-valvuloplasty severe aortic regurgitation.
Fuertes Ferre G; Latib A; Maisano F; Naganuma T; Alfieri O; Colombo A
Cardiovasc Revasc Med; 2015; 16(5):317-9. PubMed ID: 25582986
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study.
D'Errigo P; Barbanti M; Ranucci M; Onorati F; Covello RD; Rosato S; Tamburino C; Santini F; Santoro G; Seccareccia F;
Int J Cardiol; 2013 Sep; 167(5):1945-52. PubMed ID: 22633667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
